首页 | 本学科首页   官方微博 | 高级检索  
检索        

精神分裂症患者血清超敏C反应蛋白水平研究
引用本文:张光满,许华斌,李莹,黄琴,张文,吕伟伟,张娟.精神分裂症患者血清超敏C反应蛋白水平研究[J].蚌埠医学院学报,2016,41(10):1355-1357.
作者姓名:张光满  许华斌  李莹  黄琴  张文  吕伟伟  张娟
作者单位:安徽省六安市第二人民医院 特检科, 237008
基金项目:安徽省高校省级自然科学研究资助项目(KJ2013Z343)
摘    要:目的:研究精神分裂症患者血清超敏C反应蛋白(hs-CRP)水平以及抗精神病药物对hs-CRP水平的影响。方法:采用颗粒增强免疫透射比浊法检测106例首次发病精神分裂症患者(首次发病组)、138例长期服用抗精神病药物治疗患者(长期服药组)和137名体检正常健康成人(对照组)血清hs-CRP水平,比较3组差异,并对单独服用氯氮平和利培酮治疗的患者血清hs-CRP水平进行分析。同时采集标本当天对精神分裂症患者进行阳性和阴性症状量表(PANSS)评分。结果:长期服药组血清hs-CRP水平明显高于对照组(P<0.01),同时长期服药组血清hs-CRP水平高于首次发病组(P<0.05);氯氮平治疗组血清hs-CRP水平均明显高于利培酮治疗组和首次发病组(P<0.01),利培酮治疗组和首次发病组血清hs-CRP水平差异无统计学意义(P>0.05);hs-CRP>2.066 4 mg/L精神分裂症患者PANSS阳性量表分、阴性量表分、一般病理量表分和总分均高于hs-CRP<2.066 4 mg/L组(P<0.05~P<0.01),相关性分析表明血清hs-CRP的表达与精神分裂症的病情均呈正相关关系(P<0.05)。结论:精神分裂症患者血清hs-CRP水平明显升高,氯氮平治疗能上调hs-CRP的水平,hs-CRP水平与精神分裂症的病情具有相关性。

关 键 词:精神分裂症    超敏C反应蛋白    抗精神病药物
收稿时间:2014-11-30

Study of the serum level of high sensitivity C-reactive protein in schizophrenic
ZHANG Guang-man,XU Hua-bin,LI Ying,HUANG Qin,ZHANG Wen,Lü Wei-wei,ZHANG Juan.Study of the serum level of high sensitivity C-reactive protein in schizophrenic[J].Journal of Bengbu Medical College,2016,41(10):1355-1357.
Authors:ZHANG Guang-man  XU Hua-bin  LI Ying  HUANG Qin  ZHANG Wen  Lü Wei-wei  ZHANG Juan
Institution:Department of Special Clinical Laboratory, The Second People's Hospital of Lu'an, Lu'an Anhui 237008, China
Abstract:Objective:To investigate the level of serum high sensitivity C reactive protein(hs-CRP) in schizophrenic,and effect of antipsychotic drugs on the level of hs-CRP. Methods:The serum levels of hs-CRP in the first onset 106 schizophrenia patients( the first onset group) ,108 patients treated with antipsychotic drugs( long-term medication group) and 137 healthy people( control group) were detected,the difference of which was compared. The serum levels of hs-CRP in patients treated with individual clozapine and risperidone were analyzed. The scores of the positive and negative syndrome scale( PANSS) in schizophrenia patients was investigated. Results:The serum level of hs-CRP in long-term medication group was significantly higher than that in control group(P<0. 01),and the serum level of hs-CRP in long-term medication group was higher than that in the first onset group(P <0. 05). The serum level of hs-CRP in clozapine group was significantly higher than that in risperidone group and the first onset group(P<0. 01). The difference of the hs-CRP level between the risperidone group and first onset group was not statistically significant(P>0. 05). The scores of the positive scale and negative scale of PANSS,general pathology scale and total score in schizophrenia patients with hs-CRP>2. 066 4 mg/L were significantly higher than those in patients with hs-CRP < 2. 066 4 mg/L group(P<0. 05 to P<0. 01). Correlation analysis showed the expression of serum hs-CRP was positively correlated with schizophrenia severity(P<0. 05). Conclusions:The serum levels of hs-CRP in schizophrenia patients significantly increased,and the clozapine treatment can upregulate the serum level of hs-CRP. The level of hs-CRP is correlated with psychotic state.
Keywords:schizophrenia  high sensitivity C reactive protein  antipsychotic drug
本文献已被 万方数据 等数据库收录!
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号